908 Devices INC

908 Devices Inc. has issued over 3.2 million shares to satisfy earnout obligations related to its acquisition of RedWave Technology.

908 Devices Inc. shareholders re-elected three Class III directors and ratified the appointment of PricewaterhouseCoopers LLP at the 2026 Annual Meeting.

908 Devices Inc. has acquired NIRLAB AG, a Swiss company specializing in AI-powered near-infrared (NIR) spectroscopy for narcotics identification, for an upfront consideration of $15 million.

908 Devices Inc. announced robust fourth quarter and full year 2025 financial results, achieving positive Adjusted EBITDA in Q4 and providing a positive 2026 revenue outlook.

908 Devices Inc. announced strong preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2025, achieving positive Adjusted EBITDA in Q4.

908 Devices Inc. reported third quarter 2025 financial results, with year-to-date revenue up 16% and an improved Adjusted EBITDA loss, while reiterating its full-year revenue outlook.

908 Devices Inc. announced its first quarter 2026 financial results, reporting a 14% increase in total revenue to $13.4 million, driven by strong product revenue growth, while net loss from continuing operations widened.

908 Devices Inc. reported a net income of $15.3 million for the nine months ended September 30, 2025, driven by a significant gain from the divestiture of its Desktop Portfolio, despite continued operating losses from continuing operations.

908 Devices Inc. reported a net income for the six months ended June 30, 2025, driven by a significant gain from the divestiture of its Desktop Portfolio, despite an increased operating loss from continuing operations.

908 Devices' Q1 2025 results showcase revenue growth driven by the RedWave acquisition and a strategic shift following the sale of its Desktop Portfolio to Repligen.

908 Devices' Q3 2024 results show increased revenue but a significant net loss due to a goodwill impairment and acquisition-related expenses.

908 Devices' second quarter results show revenue growth driven by the RedWave acquisition, but also increased operating expenses and a net loss.

908 Devices Inc. experienced revenue growth in 2024, driven by handheld and desktop device sales, but reported a significant net loss due to increased operating expenses and a goodwill impairment charge.

908 Devices Inc. updates its executive bonus plan to include clawback provisions and files its annual report on Form 10-K, detailing financial performance and risk factors.

Kevin J. Knopp, President and CEO of 908 Devices Inc., reported the sale of 222 shares of common stock for $9.07 per share, executed under a pre-arranged Rule 10b5-1 trading plan.

Director Christopher D. Brown of 908 Devices Inc. sold 2,200 shares of common stock for an average price of $9.02, as part of a pre-arranged trading plan.

Christopher D. Brown, a Director at 908 Devices Inc., reported the sale of 20,000 shares of common stock for $8.84 per share, executed under a pre-arranged Rule 10b5-1 trading plan.

Kevin J. Knopp, President and CEO of 908 Devices Inc., reported the sale of 2,798 shares of common stock for $9.09 per share, executed under a pre-arranged Rule 10b5-1 trading plan.

Christopher D. Brown, a Director at 908 Devices Inc., has sold 9,900 shares of common stock for approximately $9.04 per share, as part of a pre-arranged trading plan.

Kevin J. Knopp, President and CEO of 908 Devices Inc., reported the sale of company stock totaling over 60,000 shares across three days in late June 2026, executed under a pre-established 10b5-1 trading plan.

908 Devices Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 11, 2026, to be held virtually.

908 Devices Inc. will hold its annual stockholders meeting virtually on June 12, 2025, to elect directors and ratify the appointment of PricewaterhouseCoopers LLP as its independent accounting firm.

908 Devices Inc. sets date for its 2025 Annual Meeting of Stockholders, focusing on director elections and ratification of the company's accounting firm.

908 Devices Inc. will hold its annual stockholders meeting virtually on June 13, 2024, to elect directors and ratify the appointment of PricewaterhouseCoopers LLP as its independent accounting firm.

908 Devices Inc. will hold its 2024 Annual Meeting of Stockholders virtually on June 13, 2024, to elect directors and ratify the appointment of its independent accounting firm.

ARK Investment Management and Catherine Wood have disclosed a reduction in their beneficial ownership of 908 Devices Inc. to 4.94%.

ARCH Venture Fund VII and its affiliates disclosed a 15.1% beneficial ownership stake in 908 Devices Inc. as of March 31, 2026.

State Street Corporation and its subsidiary SSGA Funds Management, Inc. reported a combined beneficial ownership of 1.6% of 908 Devices Inc. common stock.

First Light Asset Management and Mathew P. Arens report a 12.93% beneficial ownership stake in 908 Devices Inc. common stock.

First Light Asset Management, LLC and Mathew P. Arens have reported a beneficial ownership of 9.84% in 908 Devices Inc. common stock.

ARK Investment Management LLC and Catherine D. Wood have disclosed a continued beneficial ownership of 5.41% in 908 Devices Inc. common stock.